In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 438 for your search:
Drug:  carmustine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050100, NCT00352703

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592

3.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 65
Sponsor:
Protocol IDs: VU-CNS-1, NCI-V85-0222

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCSD-88612, NCI-V89-0023

7.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UTHSC-9235011015, SACI-IDD-003, UTHSC-IDD-003, NCI-V93-0321

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9305, CDR0000063286, NCT00002545

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: MRC-LEUK-MYEL-VII, EU-94030, NCT00002599

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-937252, SWOG-9503, NCCTG-93-72-52

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: Other
Protocol IDs: EORTC-26882, NCT00002620

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 to 74
Sponsor: Other
Protocol IDs: MRC-LEUK-MYEL-VIII, EU-94031, NCT00002653

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-2394, SWOG-9508, E2394

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 80
Sponsor: Other
Protocol IDs: EORTC-06954, ITA-GIMEMA-AML13, NCT00002719

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-015, P30CA008748, MSKCC-96015A1, NCI-V96-0881, NCT00002766

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GP-100-9501, NCI-V96-0952

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: DM95-047, P30CA016672, MDA-DM-95047, NCI-G96-1014, CDR0000065048, NCT00002836

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: NCI-D78-001-118, UF-777

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065658, S9704, U10CA032102, SWOG-S9704, CAN-NCIC-LY11, CALGB-59903, ECOG-S9704, LY11, NCT00004031

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor:
Protocol IDs: BNLI-LY02, EU-98039, NCT00003578

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HEALTHONE-43892, HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 65
Sponsor: Other
Protocol IDs: SNLG-NHL-Va, EU-98032, NCT00003815

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9813, CDR0000067512, ECOG-R9813, NCCTG-RTOG-9813, NCT00004259
1     
New Search